Feed: Seedol.com » Class Action News - AggScore: 45.9

Crestor Danger

5/25/11.

Crestor side effectsseem to be reported more and more as a result of the danger that is associated with taking the cholesterol reducing drug. One such side effect of Crestor includes kidney problems. For example, it has been reported that people are likely to suffer from kidney problems as much as 75 times more when compared to other cholesterol lowering drugs. Even more so, Public Citizen, a non-profit consumer advocacy group, brought notice of the six reported incidents of acute kidney failure or damage per each million Crestor prescriptions given out. It seems that Crestor use is significantly more dangerous than any other statin medications.
Dangerous side effects of Crestor unfortunately include the potentially fatal disease called Rhabdomyolysis. This condition can start as something that is simply minor with what seems to be just muscle aches, but Crestor muscle pain can eventually result in death. Rhabdomyolysis can cause severe and total muscle degeneration.… Read More

Crestor Lawsuits Being Filed

5/25/11.

Crestor attorneys. Many people are filing Crestor lawsuits because of the serious and negative association between Crestor and side effects that may result from its use. Just a few months after the U.S. Food and Drug Administration (FDA) approved the drug for distribution, seven patients who had taken Crestor reported developing a life-threatening condition called Rhabdomyolysis. In 2004, a 39 year old woman was reported to have developed this condition and died. In addition, nine patients were reported to have suffered from severe kidney damage. All of these patients reported taking Crestor in order to help with their high cholesterol levels.
Drug related lawsuits are being brought into the spotlight because of the recent Vioxx trial and award. There are some people that may be hesitant when considering whether to pursue a Crestor lawsuit, because they might not realize their symptoms or diseases could be a direct result of the drug.… Read More

Rottenstein Law Group Learns of Departure of DePuy President, Postponement of MDL Status Conference

(March 14, 2011)

DePuy spokesperson Mindy Tinsley announced that David Floyd, president of DePuy since 2007, has resigned his position “to pursue outside interests.” Floyd will leave after a short transition period. No replacement for Floyd has yet been named. DePuy, a Johnson & Johnson company, had a depuy asr recall on devices globally after the National Joint Registry of England and Wales made public data showing that, within five years, about 12% of recipients of the hip resurfacing system and about 13% of recipients of the acetabular system needed corrective surgery. A hundred or so, depuy class action lawsuits, stemming from the Depuy hip recall, have to date, been filed in the United States, and in early December of last year, the United States Judicial Panel on Multidistrict Litigation approved the depuy asr xl litigation for consolidated pretrial proceedings and assigned the case—In re: DePuy Orthopaedics, Inc. ASR Hip Implant Products (no.… Read More

DePuy Hip Recall Recipients Must Not Sign Away Their Rights

(March 4, 2011)

A DePuy ASR Hip lawyer reminded the recipients of faulty depuy asr hip implant not to sign away their rights as Johnson & Johnson offers an early hip replacement settlement. Before you accept this early hip replacement settlement offer, contact a lawyer who is knowledgeable and experienced in the depuy hip replacement recall . A depuy hip replacement recall attorney can determine if you qualify for a depuy hip lawsuit and will stand up for your rights.
DePuy considers certain expenses reasonable for patients that experience DePuy side effects. depuy hip lawsuit could be necessary to assist in covering any further treatments and surgeries resulting from your hip failure. This might require more money to settle your claim than DePuy sees necessary for extended treatments. Compensation may include payment for past, present and future medical therapies, lost wages, pain and suffering.
A second implant surgery has been necessary for some patients because of a high failure rate for two of their devices.… Read More

DePuy ASR Hip Recall Lawsuits Consolidated to Single MDL

(March 4, 2011)

A United States judicial panel on Multidistrict Litigation (MDL) has decided on consolidating depuy hip recall litigation. This action will assign all cases throughout the United States to Judge David A. Katz in the United States District Court, for the Northern District of Ohio. The number of people filing depuy hip recall Lawsuits because of DePuy asr hip replacement is on the increase following the decision to consolidate federal litigation.
Complaints against DePuy Orthopaedics, Incorporated, a subsidiary of Johnson & Johnson, contain accusations stating the company manufactured and sold defective metal-on-metal hip implants. In addition, they neglected to warn doctors and patients of the higher than acceptable risk that the implants would fail. After it became apparent that users experienced a higher rate of DePuy ASR Hip problems, a depuy hip recall should have immediately been issued.
An MDL allows such lawsuits to be consolidated under one judge for pretrial litigation to avoid duplicative discovery, inconsistent rulings and to preserve resources of the parties, witnesses and the court.… Read More

DePuy Hip Lawsuit Seeks More than $40 Million Settlement

(March 4, 2011)
Several hip replacement victims in New Brunswick are prepared to join a nationwide depuy class action Lawsuit filed in the province, suing the maker of an artificial hip implant device. With a total of 93,000 implants worldwide, this depuy hip lawsuit seeks more than $40 million for between 1,500 and 4,000 Canadians who surgically received the artificial joint.
Zoey Nicoles, lead plaintiff in New Brunswick, alleged that after suffering from a car accident in late 2009, he agreed to have a prosthetic hip implant so he could once again enjoy a normal life. He was advised by the doctor that depuy hip replacement s last more than thirty years. However, four months after surgery, Nicoles started to suffer severe pain and his mobility began to worsen again. Adding to his shock was the voluntary recall on his faulty hip implant stating that he must contact a doctor immediately.… Read More

New Artificial Joint Registries

(March 4, 2011)

The depuy hip replacement recall occurred after the ASR XL Acetabular System and the ASR Hip Resurfacing System both failed at extremely high rates. Those patients with failed hip replacements must undergo difficult revision procedures. The recall has prompted the recipients to file depuy hip lawsuit against its manufacturer, Depuy Orthopedics part of the Johnson & Johnson Family of Companies.

The need for an effective system to monitor the large number of surgeries and rapid progress in implant design has long been recognized. The National Joint Registry of England and Wales was launched in 2002 to create accurate records of all hip and knee replacement surgeries so that the quality of care given to individual patients could be improved by evaluating the data. The United States, however, does not have a similar artificial joint registry. As a result, many people, including orthopedists, did not know of the implants’ high failure rates.… Read More

DePuy Hip Replacement Recall Lacks FDA Testing

(March 4, 2011)

The approval process for medical devices, such as the depuy hip replacement , is now the subject matter of increasing scrutiny. A recent study states that most medical devices recalled for life threatening or very serious hazards were originally cleared by the United States Food and Drug Administration through an accelerated process called 510(k), or were so low risk that they were spared from review altogether.
Lead author of the study said in a statement released with the report that most of the new medical products made by different manufacturers are not scientifically tested in humans to see how effective it is. The study was published online on February 14 in the Archives of Internal Medicine. “In my view, the regulatory system is failing,” said Dr. Steven Nissen, a co-author of the study and chairman of cardiovascular medicine at the Cleveland Clinic.
According to the study, researchers examined the Food and Drug Administration’s list of high-risk device recalls issued between January 2005 and December 2009 to determine whether the devices had been approved using the extensive premarket approval (PMA) testing or less-expensive 510(k) process that does not require clinical testing or inspections of the manufacturing process.… Read More

FDA’s Fast Track of Depuy Hip Implants

(March 4, 2011)

DePuy Hip Implant Lawsuits are increasing against manufacturer, DePuy Orthopedics, part of the Johnson and Johnson Family of Companies. The United States Food and Drug Administration’s (FDA) fast track of Depuy Hip Replacement devices has led to early failure rates, leaving 12-13 percent of patients facing difficult revision surgery and at risk for metallosis.

The Food and Drug Administration’s fast track approval process is known as the 510(k) process. This course of action allows medical device makers to have their devices approved sooner, if they can prove the device is comparable to another one that has already been approved and is currently on the market. The development of this process was intended to make it easier for the FDA to deal with the considerable number of approval applications that it receives every year.
Depuy Hip Replacement is a surgical procedure wherein the hip joint is replaced by a prosthetic device.… Read More

FDA Updates Info Guide on Avandia Side Effects

(February 10, 2011)

U.S. Food and Drug Administration (FDA) announced Thursday that updated information of Avandia side effects has been added to physician labeling and patient Medication Guide.

The FDA, a federal agency of the United States, is responsible for protecting and promoting public health through the regulation and supervision of food safety, medications, and several other products. They first announced the new restrictions for prescribing and use of Avandia on September 23, 2010, after several studies showed the drug increased risk of heart failure and other cardiovascular complications.

Avandia, genetically known as rosiglitazone, is an oral anti-diabetic agent marketed by GlaxoSmithKline, the world’s third largest pharmaceutical company based in London, UK. This anti-diabetic drug, which acts primarily by increasing insulin sensitivity, improves glycemic control while reducing circulating insulin levels. It was initially approved by the FDA on May 25, 1999.

In 2001, FDA questioned GSK for downplaying the potential possibilities of heart failure associated with its manufactured anti-diabetic drug.… Read More

79% of crew employees of BA to have another strike

Almost 79 percent of the crew employees of British Airways (BA) voted devastatingly to have another strike.

These cabin crew members, who are embodied by the union called Unite, backed the move. The union did not specify when the strike will occur. The crew employees of BA’s cabin, involved in a continuing wage argument, have now voted to have a strike again for the fourth times with 13 months.

Len McCluskey, the incoming union chief of Unite, said that certainly the management of BA must now get up and listen to the protests of their dedicated competent employees. McCluskey also said that this argument will be set on by negotiation, not disagreement or legal action. She added that it is in the negotiation that the management of BA must apply itself. The Unite said that they are ready.

On the other hand, BA already issued a statement saying that only 43 percent of its 13,500 crew employees had backed a latest strike.… Read More

AA Negotiates with ITA for System Expansion

Reports said Thursday that American Airlines (AA) announced a deal with ITA to expand the system, which manages ticket reservation and other services on the airline’s website.

Monte Ford, senior vice-president of technology and chief information officer of AA, said that the world’s second largest airline has been negotiating with ITA a year before Google announced its plan to buy the Cambridge, Massachusetts-based travel industry software company.

Nonetheless, they said that they were not affected by the search giant’s pending deal, which has alarmed several travel companies. Moreover, Google’s take over remains on hold following a second request for information from the US Justice Department. Meanwhile, the company said that a deal with ITA will provide tools to help the airline sell more individualized offerings to passengers.

Previous reports said that AA has been insisting to do business on its own, pulling out its fares from various GDS operators such as Orbitz and Travelport.… Read More

Qantas’s Airbus A380 to resume flights to LA

The Airbus A380 airplanes of Qantas Airways, the largest airline in Australia, will resume its flights to Los Angeles.

The A380 has been grounded for two months because of the explosion of its engine. Qantas stated in an emailed message today that the biggest passenger plane in the world will resume its flight on January 16 from Melbourne, Australia to Los Angeles after security checks that involves Airbus, Rolls-Royce Group Plc and regulators.

In addition, the company grounded its whole A380 fleet for 23 days after the midflight explosion of the engine Rolls-Royce Trent 900 happened on November 4. After continuing the services of the A380 planes to Europe, the airline kept the planes off in the routes of trans-Pacific as it worked with regulators and makers to make sure that the power plant can operate at the 72,000 pounds of drive it claims is required.

According to Alan Joyce, the Qantas Chief Executive Officer, said that in close discussion with Rolls-Royce, they are now sure that they can start to fly the A380 to and from Los Angeles without any circumstances on the use of highest engine drive.… Read More

Expedia removes flights of American Airlines

Expedia, the biggest online travel company in the world, removed the flights of American Airlines on its website lists.

The decision strikes when the newest stream in a conflict arises again between some Web-based travel companies and American Airlines. The Expedia’s decision has a current effect on every traveler that look for American Airlines flights.

As of January 1, the website stops listing the flights of American Airlines, after the two parties fell short to resolve a disagreement about booking system. The American desires for booking system and that offers more details about its services like priority boarding.

Furthermore, the fares of American Airlines are no longer listed on any of the websites owned by Expedia, such as TripAdvisor and Hotwire. However, the flights of American Airlines stay on the corporate travel website of Expedia, the Egencia.

The biggest online travel company became the second main website in current days to discontinue the listing of flights of American Airlines.… Read More

Thousands of passengers stuck at J.F.K. International Airport

According to the federal officials, thousands of passengers became stuck on at least 28 flights at John F. Kennedy (J.F.K.) International Airport.

The stranded passengers spent more than 11 hours on the tarmac of the airport due to the paralyzing blizzard this week. The 28 flights that got stuck had one thing in common; they all started outside the area of the United States.

Moreover, the federal officials passed a regulation this year that reprimands airlines with heavy fines if the airplanes are kept on the landing strip and one for close to 11 exhausting hours. However, the new regulation pertains only to flights that start and stop in the U.S.

On the other hand, the Transportation Department has been in view of intensifying the regulation to take in international flights and the stranding can oblige the agency to act. A 24-year-old dental student named Shoham Elazar from Miami landed at Kennedy airport Tuesday on Turkish Airlines Flight 1 coming from Istanbul.… Read More